Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for incident acute myocardial ...

Oct 14 (Reuters) - BioCryst Pharmaceuticals (BCRX.O), opens new tab said on Tuesday it would buy Astria Therapeutics (ATXS.O), opens new tab in a cash-and-stock deal valued at about $700 million, ...

Global mortality rates are falling, but not among youths and young adults, according to the latest Global Burden of Disease (GBD) study published in The Lancet today and presented at the World Health ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

Postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, and orthostatic hypotension are the most common autonomic disorders encountered in clinical practice. The autoimmune ...

A novel gene therapy has been found to significantly slow the progression of Huntington’s disease, offering new hope to sufferers of the incurable disorder that destroys brain cells over time.

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

Although the name sounds endearing, the 'kissing bug' disease is nothing to fawn over. The disease is now being considered as an endemic classification, according to an August report from the Center ...

An experimental treatment for the first time slowed the devastating progression of Huntington’s disease, gene therapy company uniQure announced Wednesday, a rare hopeful advance against a cruel ...